Global and United States Atypical Hemolytic Uremic Syndrome Drug In-Depth Research Report 2017-2022

Published: Dec, 2017 | Pages: 109 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Atypical Hemolytic Uremic Syndrome Drug industry.

Major Companies
    Achillion Pharmaceuticals Inc
    Akari Therapeutics Plc
    Alexion Pharmaceuticals Inc
    Amgen Inc
    ChemoCentryx Inc
    greenovation Biotech GmbH
    Kedrion SpA
    Omeros Corp

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Atypical Hemolytic Uremic Syndrome Drug Market, byN-CC5
Atypical Hemolytic Uremic Syndrome Drug Market, byX-168
Atypical Hemolytic Uremic Syndrome Drug Market, by-006
Atypical Hemolytic Uremic Syndrome Drug Market, byR-001
Atypical Hemolytic Uremic Syndrome Drug Market, bybodina

Atypical Hemolytic Uremic Syndrome Drug Market, by Key Consumers
    Clinic
    Hospital
    Others

 Table of Contents

Global and United States Atypical Hemolytic Uremic Syndrome Drug In-Depth Research Report 2017-2022
Chapter One Global Atypical Hemolytic Uremic Syndrome Drug Market Overview
    1.1 Global Atypical Hemolytic Uremic Syndrome Drug Market Sales Volume Revenue and Price 2012-2017
    1.2 Atypical Hemolytic Uremic Syndrome Drug, by -CC5 2012-2017
        1.2.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -CC5 2012-2017
        1.2.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -CC5 2012-2017
        1.2.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by -CC5 2012-2017
        1.2.4 
        1.2.5 
    1.3 Atypical Hemolytic Uremic Syndrome Drug, by -168 2012-2017
        1.3.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -168 2012-2017
        1.3.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -168 2012-2017
        1.3.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by -168 2012-2017
        1.3.4 
        1.3.5 
    1.4 Atypical Hemolytic Uremic Syndrome Drug, by 006 2012-2017
        1.4.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by 006 2012-2017
        1.4.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by 006 2012-2017
        1.4.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by 006 2012-2017
        1.4.4 
        1.4.5 
    1.5 Atypical Hemolytic Uremic Syndrome Drug, by -001 2012-2017
        1.5.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -001 2012-2017
        1.5.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -001 2012-2017
        1.5.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by -001 2012-2017
        1.5.4 
        1.5.5 
    1.6 Atypical Hemolytic Uremic Syndrome Drug, by odina 2012-2017
        1.6.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by odina 2012-2017
        1.6.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by odina 2012-2017
        1.6.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by odina 2012-2017
        1.6.4 
        1.6.5 

Chapter Two United States Atypical Hemolytic Uremic Syndrome Drug Market Overview
    2.1 United States Atypical Hemolytic Uremic Syndrome Drug Market Sales Volume Revenue and Price 2012-2017
    2.2 Atypical Hemolytic Uremic Syndrome Drug, by -CC5 2012-2017
        2.2.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -CC5 2012-2017
        2.2.2 United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -CC5 2012-2017
        2.2.3 United States Atypical Hemolytic Uremic Syndrome Drug Price by -CC5 2012-2017
        2.2.4 
        2.2.5 
    2.3 Atypical Hemolytic Uremic Syndrome Drug, by -168 2012-2017
        2.3.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -168 2012-2017
        2.3.2 United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -168 2012-2017
        2.3.3 United States Atypical Hemolytic Uremic Syndrome Drug Price by -168 2012-2017
        2.3.4 
        2.3.5 
    2.4 Atypical Hemolytic Uremic Syndrome Drug, by 006 2012-2017
        2.4.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by 006 2012-2017
        2.4.2 United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by 006 2012-2017
        2.4.3 United States Atypical Hemolytic Uremic Syndrome Drug Price by 006 2012-2017
        2.4.4 
        2.4.5 
    2.5 Atypical Hemolytic Uremic Syndrome Drug, by -001 2012-2017
        2.5.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -001 2012-2017
        2.5.2 United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -001 2012-2017
        2.5.3 United States Atypical Hemolytic Uremic Syndrome Drug Price by -001 2012-2017
        2.5.4 
        2.5.5 
    2.6 Atypical Hemolytic Uremic Syndrome Drug, by odina 2012-2017
        2.6.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by odina 2012-2017
        2.6.2 United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by odina 2012-2017
        2.6.3 United States Atypical Hemolytic Uremic Syndrome Drug Price by odina 2012-2017
        2.6.4 
        2.6.5 

Chapter Three Atypical Hemolytic Uremic Syndrome Drug by Regions 2012-2017
    3.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Regions 2012-2017
    3.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Regions 2012-2017
    3.3 Global Atypical Hemolytic Uremic Syndrome Drug Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Atypical Hemolytic Uremic Syndrome Drug by Companies 2012-2017
    4.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Companies 2012-2017
    4.2 Global Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Atypical Hemolytic Uremic Syndrome Drug Key Product Model and Market Performance
    4.4 Global Top Companies Atypical Hemolytic Uremic Syndrome Drug Key Target Consumers and Market Performance

Chapter Five United States Atypical Hemolytic Uremic Syndrome Drug by Companies 2012-2017
    5.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Companies 2012-2017
    5.2 United States Atypical Hemolytic Uremic Syndrome Drug Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Atypical Hemolytic Uremic Syndrome Drug Key Product Model and Market Performance
    5.4 United States Top Companies Atypical Hemolytic Uremic Syndrome Drug Key Target Consumers and Market Performance

Chapter Six Global Atypical Hemolytic Uremic Syndrome Drug by Consumer 2012-2017
    6.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Consumer 2012-2017
    6.2 Clinic
    6.3 Hospital
    6.4 Others
    6.5 Consuming Habit and Preference

Chapter Seven Global Atypical Hemolytic Uremic Syndrome Drug by Consumer 2012-2017
    7.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Consumer 2012-2017
    7.2 Clinic
    7.3 Hospital
    7.4 Others
    7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Achillion Pharmaceuticals Inc
        8.1.1 Achillion Pharmaceuticals Inc Company Details and Competitors
        8.1.2 Achillion Pharmaceuticals Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.1.3 Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.1.4 Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.2 Akari Therapeutics Plc
        8.2.1 Akari Therapeutics Plc Company Details and Competitors
        8.2.2 Akari Therapeutics Plc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.2.3 Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.2.4 Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.3 Alexion Pharmaceuticals Inc
        8.3.1 Alexion Pharmaceuticals Inc Company Details and Competitors
        8.3.2 Alexion Pharmaceuticals Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.3.3 Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.3.4 Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.4 Amgen Inc
        8.4.1 Amgen Inc Company Details and Competitors
        8.4.2 Amgen Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.4.3 Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.4.4 Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.5 ChemoCentryx Inc
        8.5.1 ChemoCentryx Inc Company Details and Competitors
        8.5.2 ChemoCentryx Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.5.3 ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.5.4 ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.6 greenovation Biotech GmbH
        8.6.1 greenovation Biotech GmbH Company Details and Competitors
        8.6.2 greenovation Biotech GmbH Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.6.3 greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.6.4 greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.7 Kedrion SpA
        8.7.1 Kedrion SpA Company Details and Competitors
        8.7.2 Kedrion SpA Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.7.3 Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.7.4 Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.8 Omeros Corp
        8.8.1 Omeros Corp Company Details and Competitors
        8.8.2 Omeros Corp Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
        8.8.3 Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
        8.8.4 Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Atypical Hemolytic Uremic Syndrome Drug Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Atypical Hemolytic Uremic Syndrome Drug Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Atypical Hemolytic Uremic Syndrome Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -CC5 (2017-2022)
    10.5 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -168 (2017-2022)
    10.6 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by 006 (2017-2022)
    10.7 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -001 (2017-2022)
    10.8 Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by odina (2017-2022)

Chapter Eleven United States Atypical Hemolytic Uremic Syndrome Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -CC5 (2017-2022)
    11.5 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -168 (2017-2022)
    11.6 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by 006 (2017-2022)
    11.7 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -001 (2017-2022)
    11.8 United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by odina (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by -CC5 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -CC5 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -CC5 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by -CC5 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -CC5 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -CC5 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by -CC5 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by -168 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -168 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -168 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by -168 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -168 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -168 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by -168 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by 006 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by 006 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by 006 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by 006 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by 006 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by 006 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by 006 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by -001 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -001 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -001 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by -001 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -001 (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -001 in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by -001 (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by odina (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by odina (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by odina in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by odina (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by odina (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by odina in 2016
    Table Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by odina (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by -CC5 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -CC5 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -CC5 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by -CC5 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -CC5 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -CC5 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by -CC5 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by -168 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -168 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -168 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by -168 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -168 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -168 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by -168 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by 006 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by 006 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by 006 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by 006 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by 006 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by 006 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by 006 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by -001 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -001 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by -001 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by -001 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -001 (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by -001 in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by -001 (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by odina (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by odina (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by odina in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by odina (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by odina (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by odina in 2016
    Table United States Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by odina (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Share by Regions (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Regions in 2016
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Regions in 2017
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Regions (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Regions in 2016
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Regions in 2017
    Table Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) by Regions (2012-2017)
    Table North America Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table North America Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure North America Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Europe Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Major Companies 2016
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Major Companies 2017
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Major Companies (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Major Companies 2016
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Top Companies 2016
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share by Top Companies 2017
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Top Companies (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Top Companies 2016
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Consumer (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Consumer in 2016
    Figure Global Clinic Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Hospital Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Consumer (2012-2017)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Market Share by Consumer in 2016
    Figure United States Clinic Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Hospital Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Others Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Achillion Pharmaceuticals Inc Company Details and Competitors
    Table Achillion Pharmaceuticals Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Akari Therapeutics Plc Company Details and Competitors
    Table Akari Therapeutics Plc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Alexion Pharmaceuticals Inc Company Details and Competitors
    Table Alexion Pharmaceuticals Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Amgen Inc Company Details and Competitors
    Table Amgen Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table ChemoCentryx Inc Company Details and Competitors
    Table ChemoCentryx Inc Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table greenovation Biotech GmbH Company Details and Competitors
    Table greenovation Biotech GmbH Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Kedrion SpA Company Details and Competitors
    Table Kedrion SpA Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Omeros Corp Company Details and Competitors
    Table Omeros Corp Key Atypical Hemolytic Uremic Syndrome Drug Models and Performance
    Table Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Business SWOT Analysis and Forecast
    Table Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Share Forecast by Regions in 2022
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by Application in 2022
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -CC5 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -CC5 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by -CC5 in 2022
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -168 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -168 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by -168 in 2022
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by 006 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by 006 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by 006 in 2022
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -001 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -001 (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by -001 in 2022
    Table Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by odina (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by odina (2017-2022)
    Figure Global Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by odina in 2022
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Share Forecast by Regions in 2022
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by Application in 2022
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -CC5 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -CC5 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by -CC5 in 2022
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -168 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -168 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by -168 in 2022
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by 006 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by 006 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by 006 in 2022
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -001 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by -001 (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by -001 in 2022
    Table United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by odina (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales (K Pcs) Forecast by odina (2017-2022)
    Figure United States Atypical Hemolytic Uremic Syndrome Drug Sales Volume Market Share Forecast by odina in 2022